182 related articles for article (PubMed ID: 22374565)
1. Continuous metabolic syndrome risk score for predicting cardiovascular disease in the Chinese population.
Kang GD; Guo L; Guo ZR; Hu XS; Wu M; Yang HT
Asia Pac J Clin Nutr; 2012; 21(1):88-96. PubMed ID: 22374565
[TBL] [Abstract][Full Text] [Related]
2. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
[TBL] [Abstract][Full Text] [Related]
3. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
Persson M; Hedblad B; Nelson JJ; Berglund G
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of different definitions of metabolic syndrome in predicting cardiovascular events in a cohort of non-diabetic Tehranian adults.
Hosseinpanah F; Asghari G; Barzin M; Golkashani HA; Azizi F
Int J Cardiol; 2013 Sep; 168(1):369-74. PubMed ID: 23041003
[TBL] [Abstract][Full Text] [Related]
5. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
[TBL] [Abstract][Full Text] [Related]
6. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
[TBL] [Abstract][Full Text] [Related]
7. The metabolic syndrome and mortality: the Singapore Cardiovascular Cohort Study.
Lee J; Heng D; Ma S; Chew SK; Hughes K; Tai ES
Clin Endocrinol (Oxf); 2008 Aug; 69(2):225-30. PubMed ID: 18208579
[TBL] [Abstract][Full Text] [Related]
8. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population.
Andreadis EA; Tsourous GI; Tzavara CK; Georgiopoulos DX; Katsanou PM; Marakomichelakis GE; Diamantopoulos EJ
Am J Hypertens; 2007 May; 20(5):558-64. PubMed ID: 17485022
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
[TBL] [Abstract][Full Text] [Related]
11. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes.
Ingelsson E; Sullivan LM; Murabito JM; Fox CS; Benjamin EJ; Polak JF; Meigs JB; Keyes MJ; O'Donnell CJ; Wang TJ; D'Agostino RB; Wolf PA; Vasan RS
Diabetes; 2007 Jun; 56(6):1718-26. PubMed ID: 17369522
[TBL] [Abstract][Full Text] [Related]
13. Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the suita study.
Kokubo Y; Okamura T; Yoshimasa Y; Miyamoto Y; Kawanishi K; Kotani Y; Okayama A; Tomoike H
Hypertens Res; 2008 Nov; 31(11):2027-35. PubMed ID: 19098374
[TBL] [Abstract][Full Text] [Related]
14. The metabolic syndrome, incidence of diabetes and mortality among the elderly: the Italian Longitudinal Study of Ageing.
Noale M; Maggi S; Zanoni S; Limongi F; Zambon S; Crepaldi G;
Diabetes Metab; 2012 Apr; 38(2):135-41. PubMed ID: 22071281
[TBL] [Abstract][Full Text] [Related]
15. A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease.
Petersson U; Ostgren CJ; Brudin L; Nilsson PM
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):536-40. PubMed ID: 19357517
[TBL] [Abstract][Full Text] [Related]
16. Chinese metabolic syndrome risk score.
Hsiao FC; Wu CZ; Hsieh CH; He CT; Hung YJ; Pei D
South Med J; 2009 Feb; 102(2):159-64. PubMed ID: 19139715
[TBL] [Abstract][Full Text] [Related]
17. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
DECODE Study Group
Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
[TBL] [Abstract][Full Text] [Related]
18. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.
Athyros VG; Ganotakis ES; Tziomalos K; Papageorgiou AA; Anagnostis P; Griva T; Kargiotis K; Mitsiou EK; Karagiannis A; Mikhailidis DP
Curr Med Res Opin; 2010 Mar; 26(3):713-9. PubMed ID: 20078335
[TBL] [Abstract][Full Text] [Related]
19. The association between ankle-brachial index and cardiovascular or all-cause mortality in metabolic syndrome of elderly Chinese.
Xu Y; Li J; Luo Y; Wu Y; Zheng L; Yu J; Ma J; Gu J; Hu D
Hypertens Res; 2007 Jul; 30(7):613-9. PubMed ID: 17785929
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
